Literature DB >> 15102960

Epinephrine activates both Gs and Gi pathways, but norepinephrine activates only the Gs pathway through human beta2-adrenoceptors overexpressed in mouse heart.

Jürgen F Heubach1, Ursula Ravens, Alberto J Kaumann.   

Abstract

Isoproterenol increases and decreases contractile force at low and high concentrations, respectively, through beta(2)-adrenoceptors overexpressed in transgenic mouse heart (TG4), consistent with activation of both G(s) and G(i) proteins. Using TG4 hearts, we demonstrated that epinephrine behaves like isoproterenol, but norepinephrine does not. Epinephrine both increased (-log EC(50)M = 9.4) and decreased (-log EC(50)M = 6.5) left atrial force. Pertussis toxin (PTX) abolished the negative inotropic effects of epinephrine, consistent with mediation through G(i) protein. Norepinephrine only increased contractile force (-log EC(50)M = 7.5). Norepinephrine (10-100 microM) prevented the positive inotropic effects but hardly affected the negative inotropic effects of epinephrine. Cardiodepressive epinephrine concentrations (1-10 microM) antagonized the positive inotropic effects of norepinephrine. In the free wall of TG4 right ventricle, norepinephrine and low epinephrine concentrations caused positive inotropic effects, and high epinephrine concentrations caused PTX-sensitive negative inotropic effects, as observed in the left atrium. Epinephrine (10 nM), a concentration causing maximum increase in contractile force, and norepinephrine (1 and 100 microM) increased cAMP-dependent protein kinase activity in TG4 left ventricle. Cardiodepressive concentrations of epinephrine (1 and 100 microM) did not increase cAMP-dependent protein kinase activity. The inotropic results were simulated with a model of two beta(2)-adrenoceptor sites. For one site involved in receptor coupling to G(s), both epinephrine and norepinephrine compete. The other site, recognized by epinephrine but not by norepinephrine, leads to receptor G(i) coupling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15102960     DOI: 10.1124/mol.65.5.1313

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  43 in total

1.  Reverse takotsubo cardiomyopathy: after an episode of serotonin syndrome.

Authors:  Nishaki Kiran Mehta; Gerard Aurigemma; Zahi Rafeq; Oscar Starobin
Journal:  Tex Heart Inst J       Date:  2011

2.  Do low-affinity states of beta-adrenoceptors have roles in physiology and medicine?

Authors:  Jonathan R S Arch
Journal:  Br J Pharmacol       Date:  2004-11       Impact factor: 8.739

3.  Takotsubo Cardiomyopathy Mimicking Myocardial Infarction in a Man with Myasthenic Crisis: A Case Report and Literature Review.

Authors:  Taylor M Douglas; Perry Wengrofsky; Syed Haseeb; Eric Kupferstein; Pramod Theetha Kariyanna; Jacob Schwartz; Louis Salciccioli; Samy I McFarlane
Journal:  Am J Med Case Rep       Date:  2018-10-11

4.  Homology model and docking studies on porcine β₂ adrenoceptor: description of two binding sites.

Authors:  Marvin A Soriano-Ursúa; José Correa-Basurto; José G Trujillo-Ferrara; Alberto J Kaumann
Journal:  J Mol Model       Date:  2011-01-04       Impact factor: 1.810

Review 5.  Takotsubo Syndrome - Stress-induced Heart Failure Syndrome.

Authors:  Mary N Sheppard
Journal:  Eur Cardiol       Date:  2015-12

6.  Porcine left atrial and sinoatrial 5-HT(4) receptor-induced responses: fading of the response and influence of development.

Authors:  Joris H De Maeyer; Roel Straetemans; Jan A J Schuurkes; Romain A Lefebvre
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

7.  Regenerative Medicine: Potential Mechanisms of Cardiac Recovery in Takotsubo Cardiomyopathy.

Authors:  Andrew Y Chang; Jessie T Kittle; Sean M Wu
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-03

Review 8.  Exploring the Pathophysiology of Takotsubo Cardiomyopathy.

Authors:  Wengen Chen; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

9.  Takotsubo cardiomyopathy: reversible stress-induced cardiac insult - a stress protective mechanism.

Authors:  Sachin Kumar Amruthlal Jain; Timothy R Larsen; Anas Souqiyyeh; Shukri W David
Journal:  Am J Cardiovasc Dis       Date:  2013-02-17

Review 10.  Tako-tsubo cardiomyopathy: how to understand possible pathophysiological mechanism and the role of (123)I-MIBG imaging.

Authors:  Derk O Verschure; G Aernout Somsen; Berthe L F van Eck-Smit; Remco J J Knol; Jan Booij; Hein J Verberne
Journal:  J Nucl Cardiol       Date:  2014-01-25       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.